Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

sorLA: sorting out APP.

Sanjiv Shah1, Gang Yu

  • 1Center for Basic Neuroscience and Department of Cell Biology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA. Shah@UTSouthwestern.edu

Molecular Interventions
|March 28, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Otolith dysfunction in recurrent benign paroxysmal positional vertigo after mild traumatic brain injury.

Acta oto-laryngologica·2019
Same author

Wastewater-based epidemiology in Beijing, China: Prevalence of antibiotic use in flu season and association of pharmaceuticals and personal care products with socioeconomic characteristics.

Environment international·2019
Same author

Dark Current Reduction Strategy via a Layer-By-Layer Solution Process for a High-Performance All-Polymer Photodetector.

ACS applied materials & interfaces·2019
Same author

Combination of ozonation and electrolysis process to enhance elimination of thirty structurally diverse pharmaceuticals in aqueous solution.

Journal of hazardous materials·2019
Same author

Long noncoding RNA <i>ANRIL</i> regulates endothelial cell activities associated with coronary artery disease by up-regulating <i>CLIP1</i>, <i>EZR</i>, and <i>LYVE1</i> genes.

The Journal of biological chemistry·2019
Same author

Degradation of Ofloxacin by Perylene Diimide Supramolecular Nanofiber Sunlight-Driven Photocatalysis.

Environmental science & technology·2019
Same journal

Spindle poisons and cell fate: a tale of two pathways.

Molecular interventions·2011
Same journal

CHK1 inhibitors in combination chemotherapy: thinking beyond the cell cycle.

Molecular interventions·2011
Same journal

Finding homes for orphan cytochrome P450s: CYP4V2 and CYP4F22 in disease states.

Molecular interventions·2011
Same journal

New therapeutic approaches to combat arterial thrombosis: better drugs for old targets, novel targets, and future prospects.

Molecular interventions·2011
Same journal

The secrets of a successful clinical trial: compliance, compliance, and compliance.

Molecular interventions·2011
Same journal

Asthma therapeutics: recent strides, new hurdles.

Molecular interventions·2011
See all related articles

Alzheimer Disease is linked to amyloid-beta peptide buildup. The sorting protein-related receptor sorLA/LR11 regulates amyloid precursor processing, offering a new therapeutic target for Alzheimer Disease drug discovery.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Drug Discovery

Background:

  • Amyloid-beta peptide accumulation in the brain is a key hallmark of Alzheimer Disease.
  • Proteolytic secretases involved in amyloid-beta production are critical targets for Alzheimer Disease therapeutics.
  • Understanding the regulation of amyloid precursor processing is essential for developing new treatments.

Purpose of the Study:

  • To investigate the role of the sorting protein-related receptor sorLA/LR11 in the processing and trafficking of amyloid precursor protein (APP).
  • To identify novel molecular targets for Alzheimer Disease therapeutic intervention.

Main Methods:

  • The study likely involved molecular biology techniques to examine the interaction between sorLA/LR11 and APP.
  • Analysis of protein processing and cellular trafficking pathways related to APP.

Related Experiment Videos

Main Results:

  • Newly published results demonstrate that sorLA/LR11 regulates the processing of the amyloid-beta peptide precursor.
  • This regulation impacts the trafficking of the precursor, influencing amyloid-beta generation.

Conclusions:

  • The sorting protein-related receptor sorLA/LR11 represents a novel and alternative target for the development of molecular clinical therapeutic compounds for Alzheimer Disease.
  • Targeting sorLA/LR11 may offer a new strategy to combat Alzheimer Disease progression.